Concourse Financial Group Securities, Inc. Tela Bio, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$2.32 - $5.04 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$4.39 - $6.36 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$5.3 - $7.61 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$4.5 - $7.51 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$7.85 - $10.68 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$7.85 - $10.68 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$9.23 - $11.23 $0 - $0
Q1 2023 May 15, 2023	BUY	$9.41 - $12.03 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$6.5 - $11.5 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$7.36 - $9.15 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$5.54 - $11.49 $0 - $0
Q1 2022 May 09, 2022	BUY	$11.35 - $13.7 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$11.95 - $13.34 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$12.2 - $15.93 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$11.7 - $16.11 $0 - $0
Q1 2021 May 13, 2021	BUY	$12.84 - $17.26 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$14.61 - $17.59 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$11.64 - $16.86 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$7.75 - $22.61 $0 - $0
Q1 2020 May 13, 2020	BUY	$5.39 - $18.33 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$11.26 - $13.8 $0 - $0

Others Institutions Holding TELA

# of Institutions

Shares Held

18.3M

Call Options Held

759K

Put Options Held

100

Essex Woodlands Management, Inc. The Woodlands, TX

4.11M
Shares

$12.4 Million
2.98% of portfolio
Aigh Capital Management LLC Baltimore, MD

2.47M
Shares

$7.43 Million
2.52% of portfolio
Orbimed Advisors LLC San Diego, CA

2.16M
Shares

$6.51 Million
0.13% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

1.92M
Shares

$5.76 Million
0.29% of portfolio
Silverarc Capital Management, LLC

1.12M
Shares

$3.39 Million
0.71% of portfolio

View Full List

About TELA Bio, Inc.

Ticker TELA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 19,157,600
Market Cap $57.7M
Description
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. It provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall recon...

More about TELA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account